Laboratorios Rubió

Switch to desktop

Hydrapres

HYDRAPRES

Hydralazine

HYDRAPRES® is indicated in the treatment of:

- Essential hypertension

- Congestive heart failure

HYDRAPRES® administered as parenteral injection. It is supplied in 20 mg lyophilised powder (5 ampoule per box) or 50 mg and 25 mg tablets (30 tablets per box)

 

Hydrapres sobres

 

2014 ®Laboratorios Rubió, S.A.

Top Desktop version